Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Efficacy and Safety of Once-daily Oral Zenagamtide in Participants With Obesity (AMAZE 9)

NCT07720271 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT07720271
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07720271 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Efficacy and Safety of Once-daily Oral Zenagamtide in Participants With Obesity (AMAZE 9)
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Recruiting
Start date
August 31, 2026
Completion date
August 22, 2028
Enrollment
950 (estimated)
Sites
41

Conditions

As the registry lists them; a condition with its own page is linked.

obesity, overweight